🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Hyperphosphatemia Patients on Hemodialysis

A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders NCT07285291Phase 31 site📍 Tokyo Taisho Pharmaceutical Co., Ltd. · Tests: TS-172 20~60 mg/day, Placebo Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with Hyperphosphatemia NCT06664125Phase 22 sites📍 Guangzhou📍 Guangzhou Jemincare · Tests: JMKX003002 will be administered orally, Sevelamer carbonate A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis NCT07285304Phase 31 site📍 Tokyo Taisho Pharmaceutical Co., Ltd. · Tests: TS-172
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy